Welcome to Library
Annual Reports
RMRIMS News Bulletine
Publication of K. Pandey
 

1

Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P and Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet, 2011; 377(9764): 477-486. (Epub 2011 Jan 20)

 

2

Sundar S, Sinha PK, Verma DK, Kumar N, Alam S, Pandey K, Kumari P, Ravidas V, Chakravarty J, Verma N, Berman J, Ghalib H and Arana B. Ambisome plus miltefosine for Indian patients with kala-azar. Trans R Soc Trop Med Hyg, 2011;105(2): 115-7 (Epub 2010 Dec 3).

3

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R and Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg. 2010; 83(3): 502-506

4

Sinha PK, Roddy P, Palma PP, Kociejowski A, Lima MA, Rabi Das VN, Gupta J, Kumar N, Mitra G, Saint-Sauveur JF, Seena S, Balasegaram M, Parreño F and Pandey K. Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India. Am J Trop Med Hyg. 2010; 83(2): 357-364.

5

Das VNR, Pandey K, Verma N, Bimal S, Lal CS, Singh D and Das P. Post-kala-azar dermal leishmaniasis(PKDL), HIV and pulmonary tuberculosis . National Medical Journal of India. 2010; 23(2): 88-89.

 

6

Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VNR, Verma RB and Das P. Awareness about Kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.  Southeast Asian journal of tropical medicine and public health. 2010; 41(1): 1-12.

 

7

Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, Ravidas VN, Kumar N, Pandey K and Das P. Estimation of under reporting of Visceral Leishmaniasis cases in Bihar, India. . American Journal of Tropical Medicine Hygiene .2010; 82(1): 9-11.


8

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene. 2009; 80(3): 336-338.


9

Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, Datta S, Raychaudhury B, Naskar K, Haldar AK, Lal CS, Pandey K, Das VN, Das P and Roy S. Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells. Infection and immunity, 2009, 77(6): 2330-2342.


10

Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of  mphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.


11

Khan AM, Pandey K, Kumar V, Dutta P, Das P and Mahanta J. Sample survey for indigenous cases of kala-azar in Assam by rk39 dipstick test. Indian J Med Res. 2009; 129(3): 327-328.


12

Singh D, Pandey K, Das VN, Das S, Kumar S, Topno RK and Das P. Novel noninvasive method for diagnosis of visceral leishmaniasis by rK39 testing of sputum samples. J Clin Microbiol. 2009; 47(8): 2684-2685.


13

Pandey K, Sinha PK, Das VN, Bimal S, Singh SK and Das P. Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario. Clinical Medicine: Pathology, 2009; 2: 1–4.

 

14

Pandey K, Sinha PK, Das VN, Nawin Kumar, Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


15

Bimal S, Singh SK, Sinha S, Pandey K, Sinha PK, Ranjan A, Bhattacharya SK and Das P. Leishmania donovani: Role of CD2 on CD4+ T – cell function in Visceral leishmaniasis. Exp. Parasitol., 2008; 118(2): 238-246.

16

Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D and Bhattacharya SK. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann. Trop. Med. & Parasitol, (2008); 102(2): 119-125.

17

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Lal CS, Bimal S, Verma N and Das P. HIV infection, visceral leishmaniasis and Guillain –Barre syndrome in same patient: a case report. Ann. Trop. Med. & Parasitol, 2008; 102(2): 185-188.

18

Mookerjee Basu J, Mookerjee A, Banerjee R, Saha M, Singh S, Naskar K, Tripathy G, Sinha PK, Pandey K, Sundar S, Bimal S, Pradeep Das, Choudhuri SK and Roy S. Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection. Antimicrob Agents Chemother, 2008; 52(3): 1080-1093.


19

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

20

Pandey K, Sinha PK, Rabidas V, Kumar N, Bimal S, Verma N, Lal C and Das P. HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report. Cases Journal, 2008; 1: 183.


21

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Verma N, Lal CS, Das P and Bhattacharya SK. Miltefosine in the Treatment of a case of Visceral Leishmaniasis with Renal Dysfunction. Ann Trop Med Parasitol., 2007;101(7): 649-651.

22

Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H and Ganguly NK. Phase IV Trial of Miltefosine in the Treatment of Indian Visceral Leishmaniasis.J Infect Dis. 2007; 196(4): 591-598.


23

Lal CS, Kumar A, Kumar S, Pandey K, Kumar N, Bimal S, Sinha PK and Das P. Hypocholesterolemia and increased triglycerides in paediatric visceral leishmaniasis. Clinica Chimica Acta, 2007; 382(1-2): 151-153.


24

Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg. 2007; 77(3): 560 – 561.

25

Sinha PK, Bimal S, Singh SK, Pandey K, Gangopadhyay DN, And Bhattacharya SK. Pre and Post Treatment evaluation of Immunological features in Indian Visceral Leishmaniasis patient with HIV Co-Infection. Indian J Med Res., 2006; 123: 197-202.


26

Sinha PK, Ranjan A, Singh VP, Das VNR, Pandey K, Kumar N, Verma N, Lal CS, Sur D, Manna B and Bhattacharya SK. Visceral Leishmaniasis (Kala-azar)-the Bihar (India) perspective. J Infect. 2006; 53(1): 60-64.

27

Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, Siddiqui NA and Bhattacharya SK. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health, 2006; 37(1): 18-21.


28

Pranati, Bimal S, Pandey K, Sinha PK, Gupta AK, Singh SK, Sundaram S and Das P. Leishmania donovani: Immunomodulatory Role of 63KDa Leishmania Antigen in the Promotion of IFN-gamma Response (VL vs HIV-VL Co-infection). Am. J. Immunol., 2006; 2(2): 52-57.

 

29

Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK and Bhattacharya SK. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis
in Bihar. Natl Med J India, 2005; 18(3): 131-133.


30

Das VNR, Pandey K, Kumar N, Hassan SM, and Bhattacharya SK. HIV Infection, Pneumonic Patch with Tuberculosis and Hepatitis- A case Report. Journal of communicable Diseases. 2005; 37(2): 155-157.

31

Pandey K, Sinha PK, Das VN, Kumar N, Hassan SM, Verma N, Lal CS, Bimal S, Das P and Bhattacharya SK. HIV-I infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient- a case report. Ann Trop Med Parasitol. 2005; 99(8): 807-811.

32

Sinha PK, Pandey K and Bhattacharya SK. Diagnosis & Management of Leishmania/ HIV Co-Infection. Indian J Med Res., 2005; 121: 407-414.


33

Pandey K, Sinha PK, Das VNR, Sur D, Kumar Nawin, and Bhattacharya SK. Neurocysticercosis in a Patient With Visceral Leishmaniasis Co-infected With HIV: A Case Report. Infectious Disease in Clinical Practice. 2005; 13(3): 1-2.

 

34

Bimal S,  Singh S, Pandey K, Sinha PK, Das PK, Schallig H, Das P and Bhattacharya SK. Comparative evaluation of aqueous and freeze dried antigen for Sero-diagnosis of VL and PKDL cases by DAT. American Journal of Immunology, 2005; 1(2): 74-78.

 

35

Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, Ranjan A, Das P and Bhattacharya SK. Visceral Leishmaniasis and HIV Coinfection in Bihar, India. Letter to Editor, J Acquire Immune Defic Syndr. 2003; 32(1): 115-116.